Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

CHF-1512 effective in fluctuating Parkinson's disease

April 13, 2007

Renovis and Pfizer extend VR1 research collaboration

April 12, 2007

ACR-16 studied in new phase Ib trial for schizophrenia

April 12, 2007

MAESTRO-01 trial of MBP-8298 cleared to continue

April 12, 2007

Recent patents disclose novel analgesic agents

April 12, 2007

NDA filing for local dental anesthetic reversal agent NV-101

April 11, 2007

Phase IIa Alzheimer's study of MEM-1003 completes enrollment

April 11, 2007

NP-1 begins two phase IIb trials for neuropathic pain

April 11, 2007

New Nav1.8 channel blockers with potential utility in chronic pain management

April 11, 2007

Tovaxin reduces annualized relapse rate in MS

April 11, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...